Latest TAT Stories
We are advised by TAT Technologies Ltd that journalists and other readers should disregard the news release "TAT Technologies Announcing the Entry Into a New Manufacturing Contract With Embraer, Empresa Brasileira de Aeronautica S.A." nasdaq:TATTF, issued earlier today over PR Newswire, as it will
Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment.
WASHINGTON, July 20 /PRNewswire-USNewswire/ -- From the start of the HIV epidemic, it appeared that some of the people who were infected with the virus were able to ward off the fatal effects of the disease longer than others.
NOMINATED FOR "MUCHLOUD BEST ROCK VIDEO" AT THE MUCH MUSIC VIDEO AWARDS CATCH THEM ON THE VANS' WARPED TOUR FROM JULY 29TH - AUGUST 9TH NEW YORK, June 29 /PRNewswire/ -- Canadian rockers Inward Eye are set to release their debut album Throwing Bricks Instead of Kisses on August 18th (RCA Records).
A new vaginal cream containing a reawakened protein could someday prevent the transmission of HIV.
Today, during the 87th General Session of the International Association for Dental Research, convening at the Miami Beach Convention Center, a group of scientists from Nihon University
MALMO, Sweden, February 13 /PRNewswire/ -- Teleca, a world-leading supplier of software services to the mobile industry (Nordic Exchange, Small cap: TELC B) and TAT, a Swedish user interface software technology company offering attractive UI differentiation and user experiences on mobile devices, today announced a cooperation whereby Teleca will become a partner of TAT for integration and customization services worldwide. (Logo: http://www.newscom.com/cgi-bin/prnh/20090213/337889 )...
Scientists have unraveled in unprecedented detail the cascade of events that go wrong in brain cells affected by HIV, a virus whose assault on the nervous system continues unabated despite antiviral medications that can keep the virus at bay for years in the rest of the body.
WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
Panacos Pharmaceuticals, Inc.